Let’s take a moment to analyze TrendTrade2016. Based on his posts, he is consistently negative and contrarian, labeling nearly everything “toxic” or “clowns” regardless of actual performance. He thrives on drama and attention, frequently using ALL CAPS, exclamation points, and insults to provoke reactions. His focus is short-term and reactionary, often fixating on dips, dilution, or promotions rather than long-term fundamentals. While he sometimes shows knowledge of financial mechanics like warrants, RS, and pre/post-market activity, his cynicism dominates, making him more of a pessimist than a constructive analyst. He also posts across multiple stocks and topics, with tangents ranging from DOGE to weed, showing a scattershot approach aimed at entertainment or ego rather than reliable insights. Overall, TrendTrade2016 comes across as a cynical, attention-seeking, short-term focused poster whose hyperbolic style makes him unreliable as a source for investment decisions.

Telvantis’ communications are fully grounded in factual, publicly disclosed information. All press releases, social media posts, and earnings commentary are based on official SEC filings, audited financials, and verified company developments. There are no false or misleading claims, no omitted material facts, and no intention to mislead investors. Highlighting revenue growth, operational performance, or upcoming strategic actions is accurate reporting of company progress, not a violation of Rule 10b-5. Any discussion of stock potential is market commentary, not fraudulent hype.

This is the bottom — now is the time to buy heavy in Telvantis (f/k/a RDAR). The stock has been shaken down by weak hands and market maker manipulation, but the fundamentals are rock solid. Revenue just hit $98.7M this quarter (+164% YoY), operating income proves the business works, and net losses are shrinking. The recent share increase fueled this growth, and the upcoming ticker/name change will bring new eyes and money. Every dip now is a perfect entry point — accumulate aggressively today and position yourself for the reset. Don’t wait.

To all the haters bashing this stock: look at the FACTS, not your fear.
• $98.7 MILLION revenue this quarter. That’s not “fluff,” that’s real business.
• 164% YoY growth – companies with numbers like this don’t just “go away.”
• Operating profit is already here – the model works. Losses are shrinking fast.
• Shares increased? Yes, because that’s how growth is funded. Without it, we wouldn’t have this kind of revenue explosion. That’s called building, not failing.
• Ticker/Name change coming – once Telvantis is official, all the baggage of “old RDAR” disappears. Fresh eyes, fresh money, fresh momentum.
• Market Makers are playing games – stacking the ask, walking it down, shaking out weak hands so they can load cheaper. Classic OTC manipulation.
Haters can’t argue with numbers – and the numbers say this company is scaling fast.
Every dip is manufactured… every bounce is smart money loading.
I’m here for the reset, the run, and the recovery. Telvantis is not dead – it’s just getting started.

Everyone needs to take a deep breath and actually look at the facts:
Revenue Explosion – $98.7 MILLION this quarter vs $37M last year = 164% growth YoY.
Operations Are Profitable – $1.8M operating income. The business itself is working.
Losses Shrinking – Net loss cut from -$2.9M last year to -$2.2M now.
Big Picture – This company isn’t a shell, it’s doing real business with real revenue.
Yes, the share count went from ~4.4B to 7.1B – but let’s be clear:
Those shares brought in capital and partnerships that allowed revenue to scale from $37M ? $98M.
Without that added equity, the growth we’re seeing today wouldn’t have happened.
This is how early-stage growth companies fund the ramp — and the numbers prove it’s working.
And here’s the kicker:
Telvantis rebrand + ticker/name change is in motion. When this goes through, the market will stop treating it like “old RDAR” and start seeing it as the growth arm of Mexedia’s global ecosystem. That’s a complete reset in perception.
This dip? Just weak hands shaking out. The financials PROVE growth is real, and once the ticker change drops, we’ll see new money, new eyes, and new momentum flood in.
I’ve said it before and I’ll say it again: you don’t get 164% YoY growth and ignore it at .001s. The reset is coming.

Disappointed but Still Watching — Telvantis, Do Better

So as many of us know, there was supposed to be big news released by Telvantis this week, supposedly tied to their board of directors meeting. Hype was built, and expectations were raised — not by random speculation, but by language from the company itself and those tied to it.

Now here we are — the week is wrapping up, and not one official announcement has been made.

This kind of buildup without follow-through leaves longtime, faithful investors feeling misled and frustrated. Hope and positivity were encouraged, but transparency and timing were missing.

Let this be a reminder to Telvantis leadership: If you're going to hint at something major, follow through or don’t say anything at all until it’s real.

We’re not here to be strung along — we’re here to support real growth and actual news.

Eyes are still on this company, but trust needs to be earned — not stretched thin.

RDAR / TELVANTIS — TIME TO IGNITE THE FIRE
We’re not just watching a stock — we’re witnessing a transformation. Telvantis has already delivered $32M in Q1–Q2 revenue, cleared all legacy debt, and laid out a transparent, aggressive roadmap to $1B+ revenue by 2029. The market hasn't caught up yet, but we know what's coming.
This is our window — and it’s WIDE OPEN.
Investors: If you believe in the story, now is the time to help it get heard. Don’t just sit on your shares. Be part of the movement that wakes up the market.
________________________________________
HOW TO GET THE WORD OUT:
1. Post on iHub, Twitter/X, Stocktwits, Reddit (r/pennystocks) — use the $RDAR or $TELV ticker and hashtags like #Telvantis #RDAR #TechTelecom #UplistWatch #MicrocapMomentum
2. Share key articles from Nasdaq, NewMediaWire, and Telvantis press releases — they speak volumes about revenue, growth, and the uplist roadmap.
3. Engage respectfully on other boards with undervalued tech discussions — Telvantis deserves to be mentioned.
4. Create short summaries or memes — help others digest the opportunity in a format that sticks.
5. Tag influencers who focus on microcap turnarounds or telecom/tech innovations.
________________________________________
This is not just hype — it's facts + future + firepower.
The ones who get in before the crowd — and help build that crowd — stand to benefit the most.
Let’s light it up. The Telvantis engine is running — let’s hit the gas.
#RDAR #TELVANTIS #NEXTGEN #Uplisting2025 #GroundFloorPlay #0to100

Telvantis is emerging from its legacy issues ready for real growth. With a diversified and scalable business model, consistent financial execution, and clear strategic direction, the company has the foundation to transform from a micro-cap telecom play into a recognized industry contender.

It's a high-risk, high-potential story—but as Telvantis continues to deliver and build credibility, the upside could be meaningful for early believers.

Totally agree — the board meeting results will be key to understanding the company’s direction and plans ahead. Clear updates from the board can boost investor confidence, attract new interest, and help drive the stock higher as the company executes its growth strategy. I’m looking forward to hearing what they share!

Hold Strong — Don’t Sell Into Fear!

Right now, RDAR is showing strong support around $0.0014, with big buyers ready to defend the stock and keep it steady. The current selling pressure at $0.0015–$0.0016 is normal market maker activity trying to keep things controlled — but that doesn’t mean the price won’t move higher.

Remember, volatility and tight trading ranges are part of the game in microcap stocks. Selling now out of fear only hands the opportunity to others. The smart move is to hold tight and watch as RDAR builds its foundation for the next breakout.

Stay patient, stay focused, and be ready to ride the wave when the price breaks through these levels with strong volume. This is not the time to sell — it’s the time to prepare for what’s coming!

While skepticism is healthy in OTC markets, some of the points raised here overlook key facts:

Stock Price History & Volume:
Yes, the stock peaked near $0.0029 on heavy volume last October, but that was a period of significant corporate developments and market interest. Microcap and OTC stocks frequently experience volatility due to thin liquidity and speculative trading — it’s part of the nature of this market segment, not necessarily a sign of manipulation.

Share Structure & Conversions:
The current share count has indeed increased with conversions adding roughly $3 million worth of shares, expanding to billions in the float. However, this is typical as companies raise capital to fund growth. It’s important to balance share count increases against how effectively that capital is deployed — Telvantis is focusing on scaling its communications platform and expanding revenues.

Alleged False OTC Filings:
Claims of “false OTC filings” must be substantiated with evidence. The company’s SEC filings, including recent audited financials and Form 1-Z termination of the Reg A offering, show a pattern of compliance and transparency.

Social Media Influencer Pumping:
Social media can drive short-term hype in microcaps, but Telvantis’s fundamentals and product development stand on their own. The company is investing in technology and partnerships, which are more sustainable drivers than mere hype cycles.

Price Declines After Pump:
Price pullbacks after spikes are common and natural. They do not necessarily indicate failure but reflect normal market dynamics, especially in highly speculative stocks. Investors should focus on long-term business performance rather than short-term price swings.

In summary, while caution is warranted, painting Telvantis as solely a pump-and-dump story ignores their ongoing operational progress and regulatory compliance. Investors should look beyond price volatility and consider the company’s strategic growth initiatives and financial filings to form a more complete picture.

Critical Review of Bubae’s Posts on RDAR (Telvantis) on InvestorsHub
Bubae has been an outspoken critic on the RDAR board, particularly focused on the Regulation A offering, alleged share dilution, financial struggles, and stock price volatility. While his vigilance is understandable from a shareholder perspective, several of his points warrant a closer, more balanced examination.

1. Regulation A Offering and Share Dilution
Bubae’s claim: The Reg A offering risks excessive dilution, especially with performance bonus notes converting at a discount, potentially hurting shareholder value.

Why this may be an overstatement:

The Reg A raise was capped at $4.5 million, a relatively modest amount aimed at fueling growth initiatives and product development, not reckless dilution.

Performance bonus notes structured with a discount are common incentive tools to align management’s goals with company growth and shareholder returns. These incentives typically vest on performance milestones, helping ensure management delivers value.

Importantly, the company filed a Form 1-Z to terminate the Reg A offering responsibly, signaling compliance and an intention to protect shareholders from prolonged dilution risk.

2. Financial Performance and Buyback Program
Bubae’s claim: The company is cash flow negative with nearly $2 million net loss in Q1, making a share buyback program unrealistic and potentially misleading.

Critical perspective:

Many early-stage technology companies operate with short-term losses as they invest in product development and market expansion; this is not inherently negative if backed by a sound growth strategy.

The company’s announcement of a buyback program can be seen as a commitment to shareholder value and confidence in future cash flows, even if initial losses exist.

Buybacks can be funded opportunistically, including via non-operational cash sources or capital restructuring, not solely from current cash flow.

3. Stock Price Volatility and Reverse Split Speculation
Bubae’s claim: The stock’s price fluctuations suggest manipulation or a reverse stock split planned to facilitate the Reg A offering pricing.

Balanced view:

Volatility is typical for OTC and early-stage stocks, especially in microcap sectors, and does not necessarily imply manipulation.

Reverse splits are often strategic tools to maintain listing standards or improve marketability, which can be positive for attracting institutional investors and improving liquidity.

The company’s proactive communication and SEC filings show transparency around capital actions rather than attempts to mislead investors.

Supporting Evidence & Summary
Regulatory Compliance: Telvantis filed all required SEC forms (including Form 1-Z) timely, evidencing regulatory diligence.

Business Strategy: The Reg A proceeds aimed at expanding the user base and product enhancements demonstrate a forward-looking growth plan rather than desperation.

Market Norms: Early losses and stock volatility are commonplace in emerging technology firms. Investors should evaluate long-term potential, not just short-term financial snapshots.

Conclusion
While Bubae raises some concerns valid in a highly speculative OTC environment, his perspective sometimes overlooks the broader strategic context and standard corporate finance practices. Telvantis’s approach appears measured and compliant, focusing on growth and shareholder value rather than reckless dilution or manipulation.

Investors should weigh both risks and growth opportunities carefully and look beyond short-term stock price moves or headline losses to the company’s fundamentals and long-term vision.

MM Games Exposed — Don’t Let Them Shake You!

Every time we get close to the breakout, same pattern: they stack the ask at .0017, pull volume just enough to bait retail, then dump back into weakness and reload lower. Classic MM rotation — CDEL, CSTI, ETRF all taking turns flashing walls, flipping roles, and scooping shares from weak hands.

This isn’t retail selling — it’s orchestration.

They’re controlling the range, not because RDAR is weak — but because they KNOW what’s coming. We’re sitting on a net-profitable company, a pending acquisition, and breakout-level technicals. That’s why they keep walking it — load, dump, reload.

Do NOT sell into fear. That’s exactly what they want. The second you panic, they’re filling their bags with your shares. If you understand the setup, you know this isn’t the time to fold — it’s the time to hold.

Volume through .0017 with conviction breaks this game wide open. No reason we can’t see .0020+ once that wall cracks.

Eyes open. Patience strong. The breakout belongs to the ones who don’t fold under pressure.

What a day! RDAR closed at $0.0016 with a massive 194 MILLION shares traded, showing clear signs of life and accumulation.

We saw relentless support at $0.0014–0.0015 throughout the day, and the close at the ask shows buyers are in control .

This wasn’t just a low-volume drift — this was powerful, organic volume building behind the scenes. The sell walls at $0.0016 started thinning, and market makers didn’t slap them back as hard — the shift is real.

Telvantis is NOT your typical OTC play. This is real revenue, real profit, no reverse split, no toxic debt, buybacks in motion, and a clear path to uplisting.

This thing has legs, and when it runs — it won’t be a flash in the pan. It’ll be a steady, crushing stair-step climb. Let’s not forget what’s coming:

$98M revenue (first 6 months)
$1.8M profit
$1M share buyback
No reverse split / No convertible debt
NASDAQ/NYSE up-listing plan
August 14 financials approaching
Institutional interest rising
Parent company already trading over $50+

This is the calm before the storm. Many missed TSNP, ENZC, and AITX before they exploded. Don’t blink — RDAR is laying the foundation brick by brick.

Hold tight. Eyes on the prize. $0.0016 today, much higher tomorrow.

The MM trap is flipping.
They’ve run the same shakeout over and over — but this time, we’re holding the floor and starving the ask.

They’re stacking fake walls at $0.0017–$0.0018, hoping we fold.
But we’re not chasing. We’re not dumping.

Volume’s coming. $0.002+ is back on deck.
They’re running out of time — and shares.

Hold strong. Let them panic.

Nailed it. This isn’t just hope — it’s backed by numbers and timing. Q2 sets the foundation, and once AmeriCrew hits the books, it’s game on. The market’s sleeping on the profit potential here. Sub-penny won’t last.

I like to think of RDAR is like a fragile egg…

You can either:
🥚 Crack it too early and throw away the run
OR
Let the pressure build and watch it hatch into something big

MMs are walking it tight, sitting right on VWAP.
One wrong move from them — and this thing pops hard.

Handle it with patience. Breakout comes fast and messy

RDAR holding VWAP at $0.001614 after $118K+ in volume in the first hour.
MMs are walking the line, trying to exhaust retail. This is the pressure zone — a break above and they lose control.
This isn't fading — it's loading.

Don’t fall for the MM scare tactics.

They’re stacking .0017 to look heavy while quietly soaking up dips at .0015–.0016.
This is a classic bluff — baiting weak hands to sell so they can reload cheap before the next push.

Volume is still strong. The setup is still intact.
Shakeout before breakout.

Watch the walls — they’ll vanish when it’s go time.

RDAR - 72M Volume in First 45 Minutes!
The beast is awake — RDAR is moving with serious momentum!

$0.0016 bid wall holding strong

$0.0017 getting chipped with size still pressing

Over 72 MILLION shares traded already, and we’re not even an hour in!

MM walls at .0017 and .0018 could be bluffing — if they pull, this thing flies.

This isn’t your average OTC crawl… this is real pressure, real eyes, and real setup.
Break .0017 and we’re staring down .002+ fast.

Massive strength into the close! Broke through heavy resistance at $0.0017 with solid volume — the MM walls couldn’t hold. Accumulation zones at $0.0015–$0.0016 were loaded all day. This setup is primed for a breakout next week. Momentum is real. Eyes on $0.002+ Monday! 🧨💥🚀

also watch for the 999

Best advice for today’s trading:
Hold your ground — don’t sell under $0.002. Market makers will try to create false ceilings and fake support zones to shake weak hands.
Stay disciplined. Watch Level 2 closely, follow the volume, and don’t fall for emotional traps. Let the setup come to you.

You raise valid points about profitability and share structure—these are key issues for $RDAR investors.

Yes, the $1.8M figure is pre-financing costs, so the net profit might be lower or even negative once all expenses are considered. That’s typical for companies in growth or turnaround phases.

$98M in revenue with slim or no net profit highlights the challenge of scaling profitably, especially in competitive or capital-intensive industries. But strong revenue growth is often the first step before margins improve.

The 6.7 billion shares outstanding definitely signals dilution risk, which investors must factor in. Settling convertible debt recently is a step towards stabilizing this.

Many OTC stocks trade with higher risk and volatility, but that also means potential for rapid changes if the company can turn profitable or announce positive catalysts.

Bottom line: it’s a high-risk, high-reward scenario. The company is still navigating growth and capital structure challenges. Investors should watch closely for improving margins and management’s execution.

While it’s true that Mexedia’s subsidiaries have historically operated with negative cash flow and have had significant convertible debt, the company has recently made meaningful strides to improve its financial health and position for growth:

Evidence and Positive Outlook:
Convertible Debt Settlement
The company successfully settled all outstanding convertible debt as of December 2024. This is a major milestone because it removes a significant overhang of potential dilution and financial uncertainty, clearing the way for a stronger capital structure. Settling convertible debt reduces pressure from debt holders converting shares at very low prices and signals a cleaner balance sheet.

Improved Focus on Growth and Cash Flow
Although past financials show cash flow challenges, the company is actively pursuing growth initiatives and acquisitions to build sustainable revenue streams. The commitment to operational improvement is promising for turning cash flow positive in the near future.

Buyback Program Shows Commitment to Shareholder Value
The announced buyback program, while still early in execution, demonstrates management’s intent to support the stock price and offset dilution. Even initiating a buyback in the current environment reflects confidence in the company’s prospects.

Gross Margins Indicate Strong Business Potential
With gross margins around 73%, the company’s core operations have solid profitability potential. The negative net margins reflect early-stage investments and operational scaling — typical for growing businesses.

Share Structure Transparency and Reset
The share count increasing to over 6.7 billion reflects past dilution but also a reset that can enable future capital raises on clearer terms. The company now has a foundation to build shareholder value without the overhang of convertible debt.

In Summary:
The evidence shows that while Mexedia’s subsidiaries have faced financial challenges, they have made concrete steps to address debt, improve capital structure, and position for growth. The settlement of convertible debt, focus on operational improvement, and introduction of a buyback program all point toward a positive trajectory. This lays the groundwork for future cash flow positivity and increased shareholder value, which is promising for investors holding RDAR shares.

Exactly — and that’s what makes it even more bullish.

$1.8M net profit in the first half of 2025, with revenue growth accelerating each month (May alone brought in over $20.6M) — and the company still trades under a $10M market cap?

This isn’t a bloated trip zero shell. It’s a revenue-generating tech company that:

Has zero toxic debt

Is cash flow positive

Completed a PCAOB audit

Is actively executing a $1M buyback

Just filed for a name/ticker change and uplisting prep

So yes — this isn’t a trip stock anymore. That’s the point.

The real value is that it’s still priced like one, and the market hasn't caught up yet. When it does, the people loading at $0.0013–$0.0015 will be sitting pretty.

$1.8 million in net profit is actually strong for an OTC company, especially one that just cleared legacy debt and is reinvesting into growth.

RDAR/Telvantis is cash flow positive, has no toxic debt, and is executing a $1M share buyback — that’s not "terrible," that’s positioning for a breakout.

The share structure doesn’t matter yet — because if they’re actively reducing the float and locking shares through buybacks or affiliate accumulation, the float becomes tighter fast. That’s when runs happen.

Profitability + upcoming name/ticker change + stealth accumulation? That’s not bearish, that’s preparation.

Avoid triggering breakout buying
Big players (or the company itself) don’t want retail momentum chasing too early. They want control — not a spike.

🔹 Accumulate at lower prices without retail catching on
Late Form T blocks let them load millions at $0.0015–$0.0016 without lighting up scanners or L2 watchers.

🔹 Downplay bullish sentiment from Q2 news
If the chart looked too strong today, it might’ve sparked FOMO. Keeping the candle weak helps them load longer.

🔹 Control chart behavior, keeping the stock under key resistance
Holding it under $0.0016 until they’re done loading prevents early breakouts — then they let it go when they’re positioned.

When you see trades hidden from view, showing only after close, you’re not looking at randomness — you’re seeing intentional structure.

Exactly. Those Form T prints weren’t just noise — they were massive blocks at strategic levels. Whoever was buying didn’t want eyes on it until the close, probably to avoid alerting traders or triggering momentum.

You don’t dump millions at $0.0015 and $0.0016 unless you know something. Whether it’s the ticker change, merger finalization, or a short squeeze setup — the accumulation feels deliberate.

If they open above $0.0015 tomorrow and hold it, it’s game on.

Just wanted to clarify a common misconception — while OTC Markets don’t have formal pre-market or after-hours sessions like NASDAQ, trades can still occur close to or shortly after the official close. The “form T” trades you’re seeing are real transactions reported late, often large blocks that settle after hours. These trades provide important insights into buying and selling activity that can influence the next day’s price action. So, they’re definitely valid and worth paying attention to. Hope that helps clear things up!